Join Futurist Eric Fry for The Road to AGI Summit

A secretive, controversial AI development could soon reinvent the world we live in. Eric Fry shows you where to move your money before it’s too late.

Thu, August 22 at 1:00PM ET
 
 
 
 

Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Why Apple Shares Are Being Pulled Sideways

Tech is transforming from growth stocks into value stocks. But growth and power will sustain long-term investment in AAPL stock.

Sundial Growers or Indiva: Which is the Better Buy?

Sundial Growers owns 18.45% of Indiva, who manufacture Wana Brand edibles in Canada. Is SNDL stock a buy or is Indiva a better call?

Zomedica Stock Will Be Worth The Risk After Another Drop

Another pullback in ZOM stock will put this long-term speculative play's odds in your favor if its Truforma product catches on.

Trade RIOT Stock as Bitcoin’s Price Volatility Soars to New Heights

Riot Blockchain is a worthwhile gamble for speculators unwilling to buy the underlying cryptocurrency but instead want to own the established miner

Here’s a Way to Own Alibaba’s Stock Without Company Specific Risk

An interesting buyer made a multi-million-dollar purchase of Alibaba recently. Should you buy BABA stock or opt for the dark horse?

Dare to Trade the Range in Nio for Faster Profits

The EV stock field is vast but there are only few sure things among them. NIO Stock offers short-term opportunities and long-term success.

Here’s Why I’m Not Tempted to Buy Lordstown Motors Stock

RIDE stock doesn't have any revenue, making it too speculative at a time where high-quality growth stocks have also been pressured.

Be Careful About Buying the Spike in Canopy Growth

News of impending legislation to legalize marijuana in the U.S. is encouraging, but investors in CGC stock have been hurt before.

Volatility In Tilray Will Likely Continue After Its Recent Merger

Despite the recent significant pullback in TLRY stock, the cannabis space is still frothy with little potential for another up leg in Tilray.

Crypto Rumors Could Bump Palantir Stock but Won’t Help Its Fundamentals

Here's why PLTR stock could be primed for a meme stock-like rally, if it can entice young investors to jump aboard once again.

China’s Electric Vehicle Ramp-up Is Ironically Hurting Nio

Nio stock offered a tremendous ride in 2020 but this year, the situation may change as economic realities hit the Chinese EV market.

Is China’s XPeng Stock Dead Money Like Its EV Peers?

The XPeng story hit the skids in 2021 despite continued sales growth. Down 34% year-to-date, XPEV stock has likely bottomed. But is it a buy? 

Lucid Motors Stock Is A Higher-Risk Version Of Tesla

Lucid Motors stock is one of the newest ways to invest in EVs. However, Lucid investors should understand the investment is a long shot.

Asensus Surgical Investors Need To Take Long-Term View on Its Technology

Asensus claims its Senhance can do a hysterectomy for half what Intuitive's DaVinci robot costs, with renewable instruments and haptic feedback. The long haul is the only way to play ASXC stock.

Don’t Count Out Pershing Square Tontine Just Yet

Once a deal closes with Pershing Square Tontine, Ackman has also mentioned there would be a Pershing Square Tontine II investment opportunity.

General Electric’s Growth Hinges on Aviation and Renewable Energy

General Electric’s turnaround is underway but GE stock has stalled, and these two divisions are key to a return to growth mode.

3 Home Goods Stocks for Summer Improvements

Due to the pandemic, home improvement is a growing trend that doesn't seem to be going anywhere. And these home goods stocks should benefit.

A Strange GameStop: The Only Winning Move Is Not to Play

Some may see this as a short-squeeze play to ride back "to the moon." Others may see it as a screaming short, a name they can fade all the way back to under $100 per share. Yet, again, the best move with GME stock is not to play. With so much still up to chance, it's too risky to go either long or short at today's prices.

Ocugen Stock Is a Speculative Covid-19 Vaccine Bet

OCGN stock is a speculative bet. FDA approval of Covaxin would boost the shares. However, the firm's revenue potential is limited.